Medicine Overview of Ondero Met Tablet
Diarrhoea, Nausea, Vomiting, Stomach upset, Headache, Nasal congestion, Sore throat, Respiratory tract infection, Hypoglycaemia (low blood sugar level) in combination with insulin or sulphonylurea.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ondero Met 850mg/2.5mg Tablet is to be taken with food.
Ondero Met 850mg/2.5mg Tablet may cause stomach upset if taken on empty stomach.
Ondero Met 850mg/2.5mg Tablet is a combination of two antidiabetic medicines: Metformin and Linagliptin. Metformin is an anti-diabetic medication (biguanide). It works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin. Linagliptin is a DPP-4 inhibitor which works by increasing the release of insulin from the pancreas and decreasing the hormones that raise blood sugar levels. This reduces both fasting and postmeal sugar levels. Together, they provide better control of blood sugar.
In Depth Information on Ondero Met Tablet
Ondero Met Tablet related warnings
Taking linagliptin with alcohol may affect blood glucose levels in patients with diabetes.
Ondero Met 850mg/2.5mg Tablet is probably safe to use during pregnancy.
Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor.
Ondero Met 850mg/2.5mg Tablet is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Ondero Met 850mg/2.5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Ondero Met 850mg/2.5mg Tablet may be needed. Please consult your doctor.
Use of Ondero Met 850mg/2.5mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Ondero Met 850mg/2.5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Ondero Met 850mg/2.5mg Tablet may be needed. Please consult your doctor.
Ondero Met 850mg/2.5mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
No Patient Concerns found for this medicine
User Submitted Feedback For Ondero Met 850mg/2.5mg Tablet
Patients taking Ondero Met 850mg/2.5mg Tablet What were the side-effects while using Ondero Met 850mg/2.5mg Tablet? How much was the improvement? What are you using Ondero Met Tablet for?
Survey Participants: 9
“The following are the results of on-going survey on 1mg.com for Ondero Met 850mg/2.5mg Tablet. These results only indicate the perceptions of the website users. Please base your medical decisions only on the advice of a doctor or a registered medical professional.”
One of the following vendor pharmacies will deliver Ondero Met 850mg/2.5mg Tablet: STA, RPI, JVN, BMJ, HTS, VNS, DPL, MLC, OHM, SLN, HIP, RKS, HSP, MPC, PWN, TNH, ATP, ENP, RDH, OLT, AYU, FGH, TFP, NXG, HPC, SGC, BAP, JIV, DFP, DAO, QTM, MMS, PTI, SHP, ANT, MSD, LHA, RDR, GPT, ARD, RWP, UMP, RJH, NSL, SHC, CLT, HAT, QLF, BSN, SWP, OWP, USF, SBL, TRP, AAR, TOM, GTK, PLT, GBL, DLP, HZF, NDP, RSS, PEN, RHL, WSI, SCH, GHR, GTC, LCC, SGH, HMP, NTB, RUS, JVO, BAL, NVL, PPR, P2P, HBV, HEX, PVP, AYM, HGI, EQN, SJP, SAF, RPP, EVP, BTM, DVH, SDM, VRS, ABP, ATL, NNH, SBA, AAY, 9T9, THP, PMA, SHD, DHR, NVY, BHP, KHH, MDH, MAK, ZVP, RSA, SVH, DPP, RHW, SRG, SYN, MAX, ADT, PNT, IPL, NAS, OIP, PRN, MDO, MAM, GNC, INC, AGT, BBS, AMR, KHC, DGN, HNP, EMB, ESY, ZEL, VDH, GPP, SSA, WHL, BHM, SWA, BLE, IAD, BIO, BDN, JSL, KMC, DYG